Through a series of experiments, the present study eventually illustrated that GP upregulated Six3os1 expression, which then alleviated the oxidative stress in mice with CUMS-induced depression-like behavior through activation of the miR-511-3p-mediated Fezf1/AKT signaling pathway. Here, FEZF1 is linked to depressive disorder.